As anyone who has been following the weight loss wars knows, today’s treatments are far from perfect. They might be mega blockbusters, the likes of which have rarely been seen before in pharma, but that doesn’t mean they can’t be improved upon. They have to be injected – weekly. They often cause nausea. And they […]
Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces that it has secured nearly €50m of new financing, consisting of up to €37.5m […]
“Nothing for something” doesn’t sound like much of a deal. But when that “nothing” is zero tariffs on UK pharmaceutical products being sold in the US, then that’s something to shout about – in today’s world anyway. Topline details of the UK-US pharma deal were briefed earlier this week. In return for zero tariffs, the […]
Biocomposites announced expanded approval in India for STIMULAN® Rapid Cure to be mixed with antimicrobials to treat infection Biocomposites announces the expanded approval for STIMULAN® Rapid Cure in India. The approval from India’s Central Drugs Standard Control Organisation (CDSCO) allows STIMULAN® Rapid Cure to be mixed with a wider variety of antibiotics than before, including in combination, […]
People in Europe and the US rarely pay for prescription drugs out of their own pockets. In Europe, their national health services almost always pick up the tab – even if some people have to contribute by way of a prescription charge. In the US, the health insurer normally foots the bill. But things have […]
